AGÕæÈ˹ٷ½

STOCK TITAN

[Form 4] UiPath, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Form 4 highlights: On 06/30/2025 Genworth Holdings, Inc., which remains the controlling stockholder of Enact Holdings, Inc. (ticker ACT), sold 691,152 Enact common shares to the issuer under an April 30, 2025 Share Repurchase Agreement. The transaction was coded “S� (sale) and priced at $35.4867 per share, a volume-weighted figure set by the agreement. Following the sale, Genworth still owns 120,243,555 shares, representing approximately 81 % of the outstanding stock, and reports the position as direct ownership.

The filing signals incremental execution of the parent-level liquidity strategy while modestly reducing Enact’s public float through an issuer buyback. No derivative securities were involved, and no change in board or executive relationships was disclosed.

Punti salienti del Modulo 4: Il 30/06/2025 Genworth Holdings, Inc., che rimane l'azionista di controllo di Enact Holdings, Inc. (ticker ACT), ha venduto 691.152 azioni ordinarie di Enact all'emittente nell'ambito di un Accordo di Riacquisto Azionario del 30 aprile 2025. La transazione è stata codificata come “S� (vendita) e il prezzo è stato di 35,4867 $ per azione, una cifra ponderata per il volume stabilita dall'accordo. Dopo la vendita, Genworth detiene ancora 120.243.555 azioni, rappresentando circa il 81% del capitale sociale in circolazione, e segnala la posizione come proprietà diretta.

La comunicazione indica un'esecuzione incrementale della strategia di liquidità a livello di società madre, riducendo modestamente il flottante pubblico di Enact tramite un riacquisto da parte dell'emittente. Non sono stati coinvolti strumenti derivati e non è stata comunicata alcuna modifica nelle relazioni con il consiglio di amministrazione o i dirigenti.

Aspectos destacados del Formulario 4: El 30/06/2025, Genworth Holdings, Inc., que sigue siendo el accionista mayoritario de Enact Holdings, Inc. (símbolo ACT), vendió 691.152 acciones comunes de Enact al emisor en virtud de un Acuerdo de Recompra de Acciones del 30 de abril de 2025. La transacción se codificó como “S� (venta) y se fijó un precio de 35,4867 $ por acción, un valor ponderado por volumen establecido por el acuerdo. Tras la venta, Genworth aún posee 120.243.555 acciones, lo que representa aproximadamente el 81% de las acciones en circulación, y reporta la posición como propiedad directa.

La presentación señala una ejecución incremental de la estrategia de liquidez a nivel matriz, reduciendo modestamente el flotante público de Enact mediante una recompra por parte del emisor. No se involucraron valores derivados y no se informó ningún cambio en las relaciones con la junta o ejecutivos.

Form 4 주요 ë‚´ìš©: 2025ë…� 6ì›� 30ì�, Enact Holdings, Inc.(티커 ACT)ì� ì§€ë°� 주주ì� Genworth Holdings, Inc.ê°€ 2025ë…� 4ì›� 30ì� ì£¼ì‹ ìž¬ë§¤ìž� 계약ì—� ë”°ë¼ ë°œí–‰ì‚¬ì— 691,152ì£¼ì˜ Enact 보통주를 매ë„했습니다. 거래ëŠ� “Sâ€�(íŒë§¤)ë¡� 분류ë˜ì—ˆìœ¼ë©°, 계약ì—� ì˜í•´ ì •í•´ì§� 거래ëŸ� ê°€ì¤� í‰ê·  ê°€ê²©ì¸ ì£¼ë‹¹ $35.4867ì—� ì´ë£¨ì–´ì¡ŒìŠµë‹ˆë‹�. ë§¤ë„ í›� GenworthëŠ� 여전íž� 120,243,555주를 보유하고 있으ë©�, ì´ëŠ” 발행 주ì‹ì� ì•� 81%ì—� 해당하며, ì§ì ‘ 소유ë¡� 보고하고 있습니다.

ì´ë²ˆ ì‹ ê³ ëŠ� 모회ì‚� ì°¨ì›ì� 유ë™ì„� ì „ëžµì� ì ì§„ì ìœ¼ë¡� 실행하는 ë™ì‹œì—� 발행ì‚� ìž¬ë§¤ìž…ì„ í†µí•´ Enactì� 공개 ì£¼ì‹ ìˆ˜ë¥¼ ì†Œí­ ì¤„ì˜€ìŒì„ 나타냅니ë‹�. íŒŒìƒ ì¦ê¶Œì€ í¬í•¨ë˜ì§€ 않았으며, ì´ì‚¬íšŒë‚˜ ê²½ì˜ì§„ê³¼ì� ê´€ê³� 변화는 공개ë˜ì§€ 않았습니ë‹�.

Points clés du Formulaire 4 : Le 30/06/2025, Genworth Holdings, Inc., qui reste l'actionnaire majoritaire d'Enact Holdings, Inc. (symbole ACT), a vendu 691 152 actions ordinaires Enact à l'émetteur dans le cadre d'un Accord de Rachat d'Actions daté du 30 avril 2025. La transaction a été codée « S » (vente) et fixée à 35,4867 $ par action, un prix pondéré en fonction du volume défini par l'accord. Après la vente, Genworth détient toujours 120 243 555 actions, représentant environ 81 % du capital en circulation, et déclare la position comme une propriété directe.

Le dépôt indique une exécution progressive de la stratégie de liquidité au niveau de la société mère tout en réduisant modestement le flottant public d'Enact via un rachat par l'émetteur. Aucun titre dérivé n'a été impliqué et aucun changement dans les relations avec le conseil d'administration ou les dirigeants n'a été divulgué.

Formular 4 Highlights: Am 30.06.2025 verkaufte Genworth Holdings, Inc., der weiterhin kontrollierende Aktionär von Enact Holdings, Inc. (Ticker ACT), 691.152 Enact-Stammaktien an den Emittenten im Rahmen einer Aktienrückkaufvereinbarung vom 30. April 2025. Die Transaktion wurde mit „S� (Verkauf) codiert und zu einem volumengewichteten Preis von 35,4867 $ pro Aktie, wie im Vertrag festgelegt, durchgeführt. Nach dem Verkauf hält Genworth weiterhin 120.243.555 Aktien, was etwa 81 % des ausstehenden Aktienkapitals entspricht, und meldet die Position als direkten Besitz.

Die Meldung signalisiert eine schrittweise Umsetzung der Liquiditätsstrategie auf Konzernebene, während die frei handelbaren Aktien von Enact durch einen Rückkauf durch den Emittenten leicht reduziert werden. Es waren keine Derivate beteiligt, und es wurden keine Änderungen in den Beziehungen zu Vorstand oder Geschäftsführung offengelegt.

Positive
  • Issuer-level share repurchase removes 691,152 shares from the public float without open-market pressure.
  • Rule 10b5-1 structured sale reduces insider-trading risk perception and adds transparency to Genworth’s divestiture plan.
Negative
  • Continued parent-level selling indicates Genworth may keep monetizing its stake, potentially leading to future share overhang.
  • Control concentration unchanged; minority shareholders still have limited influence with Genworth retaining ~81 % ownership.

Insights

TL;DR: Parent sold 0.6 % of stake back to Enact; float shrinks slightly, control unchanged, neutral-to-mildly positive for remaining shareholders.

The 691 k-share block represents roughly 0.4 % of Enact’s 173 m share base (implied from 81 % ownership figure), so the financial impact on EPS and book value is immaterial. However, buying directly from Genworth avoids open-market pressure and signals ongoing commitment to capital return after the April 2025 repurchase agreement. Genworth’s continued 81 % ownership means governance dynamics and dual-class risk are unchanged. From a liquidity standpoint, the parent’s gradual selldown may foreshadow future secondary offerings, but the small size and fixed pricing limit market read-through today.

TL;DR: Minor insider sale via structured agreement; control remains concentrated, governance profile unchanged.

The transaction was executed pursuant to a Rule 10b5-1-compliant repurchase contract, reducing concerns of opportunistic trading. Yet, it reinforces Genworth’s ability to monetize its stake outside public markets, limiting minority shareholders� influence. Because the ownership percentage did not move materially, board composition and related-party considerations stay the same. I view the event as low impact but a useful data point on the parent’s divestiture timeline.

Punti salienti del Modulo 4: Il 30/06/2025 Genworth Holdings, Inc., che rimane l'azionista di controllo di Enact Holdings, Inc. (ticker ACT), ha venduto 691.152 azioni ordinarie di Enact all'emittente nell'ambito di un Accordo di Riacquisto Azionario del 30 aprile 2025. La transazione è stata codificata come “S� (vendita) e il prezzo è stato di 35,4867 $ per azione, una cifra ponderata per il volume stabilita dall'accordo. Dopo la vendita, Genworth detiene ancora 120.243.555 azioni, rappresentando circa il 81% del capitale sociale in circolazione, e segnala la posizione come proprietà diretta.

La comunicazione indica un'esecuzione incrementale della strategia di liquidità a livello di società madre, riducendo modestamente il flottante pubblico di Enact tramite un riacquisto da parte dell'emittente. Non sono stati coinvolti strumenti derivati e non è stata comunicata alcuna modifica nelle relazioni con il consiglio di amministrazione o i dirigenti.

Aspectos destacados del Formulario 4: El 30/06/2025, Genworth Holdings, Inc., que sigue siendo el accionista mayoritario de Enact Holdings, Inc. (símbolo ACT), vendió 691.152 acciones comunes de Enact al emisor en virtud de un Acuerdo de Recompra de Acciones del 30 de abril de 2025. La transacción se codificó como “S� (venta) y se fijó un precio de 35,4867 $ por acción, un valor ponderado por volumen establecido por el acuerdo. Tras la venta, Genworth aún posee 120.243.555 acciones, lo que representa aproximadamente el 81% de las acciones en circulación, y reporta la posición como propiedad directa.

La presentación señala una ejecución incremental de la estrategia de liquidez a nivel matriz, reduciendo modestamente el flotante público de Enact mediante una recompra por parte del emisor. No se involucraron valores derivados y no se informó ningún cambio en las relaciones con la junta o ejecutivos.

Form 4 주요 ë‚´ìš©: 2025ë…� 6ì›� 30ì�, Enact Holdings, Inc.(티커 ACT)ì� ì§€ë°� 주주ì� Genworth Holdings, Inc.ê°€ 2025ë…� 4ì›� 30ì� ì£¼ì‹ ìž¬ë§¤ìž� 계약ì—� ë”°ë¼ ë°œí–‰ì‚¬ì— 691,152ì£¼ì˜ Enact 보통주를 매ë„했습니다. 거래ëŠ� “Sâ€�(íŒë§¤)ë¡� 분류ë˜ì—ˆìœ¼ë©°, 계약ì—� ì˜í•´ ì •í•´ì§� 거래ëŸ� ê°€ì¤� í‰ê·  ê°€ê²©ì¸ ì£¼ë‹¹ $35.4867ì—� ì´ë£¨ì–´ì¡ŒìŠµë‹ˆë‹�. ë§¤ë„ í›� GenworthëŠ� 여전íž� 120,243,555주를 보유하고 있으ë©�, ì´ëŠ” 발행 주ì‹ì� ì•� 81%ì—� 해당하며, ì§ì ‘ 소유ë¡� 보고하고 있습니다.

ì´ë²ˆ ì‹ ê³ ëŠ� 모회ì‚� ì°¨ì›ì� 유ë™ì„� ì „ëžµì� ì ì§„ì ìœ¼ë¡� 실행하는 ë™ì‹œì—� 발행ì‚� ìž¬ë§¤ìž…ì„ í†µí•´ Enactì� 공개 ì£¼ì‹ ìˆ˜ë¥¼ ì†Œí­ ì¤„ì˜€ìŒì„ 나타냅니ë‹�. íŒŒìƒ ì¦ê¶Œì€ í¬í•¨ë˜ì§€ 않았으며, ì´ì‚¬íšŒë‚˜ ê²½ì˜ì§„ê³¼ì� ê´€ê³� 변화는 공개ë˜ì§€ 않았습니ë‹�.

Points clés du Formulaire 4 : Le 30/06/2025, Genworth Holdings, Inc., qui reste l'actionnaire majoritaire d'Enact Holdings, Inc. (symbole ACT), a vendu 691 152 actions ordinaires Enact à l'émetteur dans le cadre d'un Accord de Rachat d'Actions daté du 30 avril 2025. La transaction a été codée « S » (vente) et fixée à 35,4867 $ par action, un prix pondéré en fonction du volume défini par l'accord. Après la vente, Genworth détient toujours 120 243 555 actions, représentant environ 81 % du capital en circulation, et déclare la position comme une propriété directe.

Le dépôt indique une exécution progressive de la stratégie de liquidité au niveau de la société mère tout en réduisant modestement le flottant public d'Enact via un rachat par l'émetteur. Aucun titre dérivé n'a été impliqué et aucun changement dans les relations avec le conseil d'administration ou les dirigeants n'a été divulgué.

Formular 4 Highlights: Am 30.06.2025 verkaufte Genworth Holdings, Inc., der weiterhin kontrollierende Aktionär von Enact Holdings, Inc. (Ticker ACT), 691.152 Enact-Stammaktien an den Emittenten im Rahmen einer Aktienrückkaufvereinbarung vom 30. April 2025. Die Transaktion wurde mit „S� (Verkauf) codiert und zu einem volumengewichteten Preis von 35,4867 $ pro Aktie, wie im Vertrag festgelegt, durchgeführt. Nach dem Verkauf hält Genworth weiterhin 120.243.555 Aktien, was etwa 81 % des ausstehenden Aktienkapitals entspricht, und meldet die Position als direkten Besitz.

Die Meldung signalisiert eine schrittweise Umsetzung der Liquiditätsstrategie auf Konzernebene, während die frei handelbaren Aktien von Enact durch einen Rückkauf durch den Emittenten leicht reduziert werden. Es waren keine Derivate beteiligt, und es wurden keine Änderungen in den Beziehungen zu Vorstand oder Geschäftsführung offengelegt.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Somasegar Sivaramakichenane

(Last) (First) (Middle)
C/O UIPATH, INC.
ONE VANDERBILT AVENUE, 60TH FLOOR

(Street)
NEW YORK NY 10017

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
UiPath, Inc. [ PATH ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
06/26/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock 06/26/2025 A(1) 16,064(2) A $0.00 63,758 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. This grant was made pursuant to the issuer's non-employee director compensation policy.
2. Includes 16,064 Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of Issuer's Class A Common Stock upon settlement. Each Annual Director RSU vests on the earlier of the date of the following year's annual meeting (or the date immediately prior to the next annual meeting, if the non-employee director's service as a director ends at such meeting due to the director's failure to be re-elected or the director not standing for re-election), or the first anniversary of the date of grant, in each case subject to the director's continued service through such vesting date.
Remarks:
Exhibit 24 - Power of Attorney
Brad Brubaker, as Attorney-in-Fact 06/30/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many Enact (ACT) shares did Genworth sell on 06/30/2025?

691,152 common shares were sold to the issuer.

What price did the shares trade at under the repurchase agreement?

The weighted average price was $35.4867 per share, calculated per the agreement terms.

How many Enact shares does Genworth hold after the transaction?

Genworth now owns 120,243,555 shares, about 81 % of Enact’s outstanding stock.

Was the transaction open-market or a private agreement?

It was executed under a Share Repurchase Agreement dated 04/30/2025, not in the open market.

Did the filing involve any derivative securities?

No, Table II shows zero derivative activity in this Form 4.

Does this sale change Enact’s governance structure?

No, Genworth remains the controlling shareholder, so governance dynamics are unchanged.
Uipath Inc

NYSE:PATH

PATH Rankings

PATH Latest News

PATH Latest SEC Filings

PATH Stock Data

6.67B
418.01M
7.02%
67.81%
6.11%
Software - Infrastructure
Services-prepackaged Software
United States
NEW YORK